Full-Time

Scientist I

Radiochemistry

Confirmed live in the last 24 hours

Telix Pharmaceuticals

Telix Pharmaceuticals

201-500 employees

Develops targeted radiation therapies for cancer

Biotechnology
Healthcare

Mid

Sacramento, CA, USA

This is an on-site role in Sacramento, California.

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Requirements
  • Bachelor’s degree in a science-related field.
  • Minimum of 3 years of experience in cGMP radiopharmaceutical manufacturing.
  • Experience with PET diagnostic tracers (11C, 18F, 68Ga) is required.
  • Experience with radiometal chemistry (89Zr, 177Lu, 64Cu, etc) is preferred.
  • Training as an Authorized User for radioactive materials preferred.
  • Experience in radiopharmaceutical production, QC, and laboratory operations.
  • Familiarity with current GMP/GLP and regulatory requirements.
Responsibilities
  • Conduct radiopharmaceutical synthesis and quality control testing, including validations, method transfers, and troubleshooting.
  • Complete documentation, including batch records, shipping documents, inventory management, and reports, in accordance with cGMP standards and the facility’s Quality Management System.
  • Ensure compliance with radiation safety procedures, including handling, storage, and disposal of radioactive materials.
  • Serve as a Subject Matter Expert (SME) for radiochemistry tech transfer and manufacturing qualification of newly developed radiotracers for clinical use.
  • Contribute to protocol development for Telix’s global radiopharmaceutical assets.
  • Ensure contracted service standards are met and resolve issues in a timely, professional manner.
  • Support other tasks and projects as assigned by management.
Telix Pharmaceuticals

Telix Pharmaceuticals

View

Telix Pharmaceuticals develops and sells products aimed at improving the diagnosis and treatment of cancer and rare diseases. The company focuses on creating therapeutic and diagnostic solutions that use targeted radiation, which helps healthcare providers make better treatment decisions and offers personalized therapy for patients with significant medical needs. Their product pipeline includes treatments for prostate and kidney cancers, glioma, sarcoma, and bone marrow conditioning. Telix operates a global supply chain to manufacture and distribute its products, generating revenue through sales to healthcare institutions. The company emphasizes sustainability, patient care, and ethical practices, aiming to create value for patients, shareholders, and employees.

Company Stage

IPO

Total Funding

$14.8M

Headquarters

Melbourne, Australia

Founded

2015

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of ImaginAb's assets accelerates development of next-generation cancer therapies.
  • New cyclotrons in Brussels enhance production capabilities for radiopharmaceuticals.
  • Expansion of North American network strengthens distribution capabilities in a key market.

What critics are saying

  • Integration challenges with ImaginAb's technology could delay new therapy development.
  • Retirement of co-founder Andreas Kluge may disrupt leadership continuity.
  • Rapid expansion into North America could strain operational resources and pose integration risks.

What makes Telix Pharmaceuticals unique

  • Telix focuses on molecularly-targeted radiation therapy for prostate, renal, and glioblastoma cancers.
  • The company integrates diagnostics and therapy, offering personalized treatment for complex diseases.
  • Telix's global supply chain ensures availability and delivery of specialized products worldwide.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Annual Performance Bonus

Equity-Based Incentive Program

Paid Vacation

Paid Wellness Days

Hybrid Work Options

Remote Work Options